These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30212265)

  • 1. Immuno-analytical approach and its application for cardiac disease marker detection.
    El-Kased RF
    J Immunoassay Immunochem; 2018; 39(5):538-550. PubMed ID: 30212265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin I: a case study in rational antibody design for human diagnostics.
    Conroy PJ; O'Kennedy RJ; Hearty S
    Protein Eng Des Sel; 2012 Jun; 25(6):295-305. PubMed ID: 22509048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic definition of cardiac troponin I.
    Larue C; Ferrieres G; Laprade M; Calzolari C; Granier C
    Clin Chem Lab Med; 1998 Jun; 36(6):361-5. PubMed ID: 9711422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of recombinant antibody fragments for troponin I measurements.
    Altshuler EP; Vylegzhanina AV; Katrukha IA; Bereznikova AV; Serebryanaya DV
    Biochemistry (Mosc); 2012 Dec; 77(12):1362-7. PubMed ID: 23244731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac troponins--Translational biomarkers in cardiology: Theory and practice of cardiac troponin high-sensitivity assays.
    Adamcova M; Popelova-Lencova O; Jirkovsky E; Simko F; Gersl V; Sterba M
    Biofactors; 2016; 42(2):133-48. PubMed ID: 26876101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin.
    Salaun E; Drory S; Coté MA; Tremblay V; Bédard E; Steinberg C; Paré D; O'Connor K; Cieza T; Coté N; Poirier P; Douville P; Blais J; Desmeules P; Kalavrouziotis D; Mohammadi S; Voisine P; Bernier M; Pibarot P; Thériault S
    J Am Heart Assoc; 2024 Jun; 13(12):e035128. PubMed ID: 38879450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of specific inhibitor peptides in enzyme-linked immunosorbent assay (ELISA) of cardiac troponin I using immuno-dominant epitopes as competitor.
    Rezaee MA; Rasaee MJ; Mohammadnejad J
    J Immunoassay Immunochem; 2017; 38(1):72-81. PubMed ID: 27624975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric recombinant antibody fragments in cardiac troponin I immunoassay.
    Hyytiä H; Heikkilä T; Brockmann EC; Kekki H; Hedberg P; Puolakanaho T; Lövgren T; Pettersson K
    Clin Biochem; 2015 Mar; 48(4-5):347-52. PubMed ID: 25111014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity peptides for the recognition of the heart disease biomarker troponin I identified using phage display.
    Park JP; Cropek DM; Banta S
    Biotechnol Bioeng; 2010 Mar; 105(4):678-86. PubMed ID: 19891006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery.
    Yang HS; Hur M; Yi A; Kim H; Kim J
    Ann Lab Med; 2018 May; 38(3):204-211. PubMed ID: 29401554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interfering component in cardiac troponin I immunoassays-Its nature and inhibiting effect on the binding of antibodies against different epitopes.
    Eriksson S; Junikka M; Pettersson K
    Clin Biochem; 2004 Jun; 37(6):472-80. PubMed ID: 15183295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of low abundant soluble biomarkers using high sensitivity Single Molecule Counting technology.
    Hwang J; Banerjee M; Venable AS; Walden Z; Jolly J; Zimmerman C; Adkisson E; Xiao Q
    Methods; 2019 Apr; 158():69-76. PubMed ID: 30394294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Troponins: biological and clinical aspects].
    Lefèvre G
    Ann Biol Clin (Paris); 2000; 58(1):39-48. PubMed ID: 10673613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and clinical performance of two cardiac troponin I immunoassays.
    Zaman Z; De Spiegeleer S; Gerits M; Blanckaert N
    Clin Chem Lab Med; 1999 Sep; 37(9):889-97. PubMed ID: 10596955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CMOS image sensor to recognize the cardiovascular disease markers troponin I and C-reactive protein.
    Devadhasan JP; Marimuthu M; Kim S; Kim MG
    Anal Bioanal Chem; 2012 Jan; 402(2):813-21. PubMed ID: 22038585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
    Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
    Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies Against Human Cardiac Troponin I for Immunoassays II.
    Lee G; Liu S
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):169-73. PubMed ID: 26090594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fixation of anticardiac troponin I antibody and cardiac troponin I release.
    Alwan K; Chocron S; Mourand JL; Toubin G; Gauchez P; Kantelip B; Kantelip JP; Etievent JP
    J Cardiovasc Surg (Torino); 2000 Aug; 41(4):541-5. PubMed ID: 11052280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale-up production and characterization of anti-human cardiac troponin I monoclonal antibody in ascitic fluid of balb/c mice.
    Majid AR; Javad RM; Malihe P; Javad M
    J Immunoassay Immunochem; 2017; 38(4):389-399. PubMed ID: 28026995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocomposites of gold nanoparticles and graphene oxide towards an stable label-free electrochemical immunosensor for detection of cardiac marker troponin-I.
    Liu G; Qi M; Zhang Y; Cao C; Goldys EM
    Anal Chim Acta; 2016 Feb; 909():1-8. PubMed ID: 26851079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.